Correlation Between Medigen Vaccine and Tanvex BioPharma
Can any of the company-specific risk be diversified away by investing in both Medigen Vaccine and Tanvex BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Vaccine and Tanvex BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Vaccine Biologics and Tanvex BioPharma, you can compare the effects of market volatilities on Medigen Vaccine and Tanvex BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Vaccine with a short position of Tanvex BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Vaccine and Tanvex BioPharma.
Diversification Opportunities for Medigen Vaccine and Tanvex BioPharma
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Medigen and Tanvex is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Vaccine Biologics and Tanvex BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tanvex BioPharma and Medigen Vaccine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Vaccine Biologics are associated (or correlated) with Tanvex BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tanvex BioPharma has no effect on the direction of Medigen Vaccine i.e., Medigen Vaccine and Tanvex BioPharma go up and down completely randomly.
Pair Corralation between Medigen Vaccine and Tanvex BioPharma
Assuming the 90 days trading horizon Medigen Vaccine Biologics is expected to under-perform the Tanvex BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Medigen Vaccine Biologics is 1.45 times less risky than Tanvex BioPharma. The stock trades about -0.2 of its potential returns per unit of risk. The Tanvex BioPharma is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 6,940 in Tanvex BioPharma on August 30, 2024 and sell it today you would lose (180.00) from holding Tanvex BioPharma or give up 2.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Medigen Vaccine Biologics vs. Tanvex BioPharma
Performance |
| Timeline |
| Medigen Vaccine Biologics |
| Tanvex BioPharma |
Medigen Vaccine and Tanvex BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medigen Vaccine and Tanvex BioPharma
The main advantage of trading using opposite Medigen Vaccine and Tanvex BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Vaccine position performs unexpectedly, Tanvex BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tanvex BioPharma will offset losses from the drop in Tanvex BioPharma's long position.| Medigen Vaccine vs. OBI Pharma | Medigen Vaccine vs. TaiMed Biologics | Medigen Vaccine vs. Tanvex BioPharma | Medigen Vaccine vs. Adimmune Corp |
| Tanvex BioPharma vs. Medigen Vaccine Biologics | Tanvex BioPharma vs. OBI Pharma | Tanvex BioPharma vs. TaiMed Biologics | Tanvex BioPharma vs. Adimmune Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |